Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
for
Cancer
Location: Fort Worth TX, Dallas TX, Waxahachie TX, Plano TX,
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT05371756
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Nashville TN,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701656
Phase2, Recruiting
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
for
Hepatorenal Syndrome, Acute Kidney Injury
Location: Fort Worth TX, Nashville TN, Atlanta GA, Rochester MN,
Sponsor: River 2 Renal Corp.
Sex: All
Age: 18+
Code: NCT05875948
Phase2, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Fort Worth TX, Oklahoma City OK, Nashville TN,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase2, Recruiting
Trifecta-Heart cfDNA-MMDx Study
for
Heart Transplant Rejection
Location: Dallas TX, Little Rock AR, Tampa FL, Salt Lake City UT,
Sponsor: University of Alberta
Sex: All
Age: 0+
Code: NCT04707872
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Dallas TX, Plano TX, Austin TX, Houston TX,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China